Antonietta Zappu

Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.

Antonio Piga, Renzo Galanello, Gian Luca Forni et al. · PubMed · 2006 · 269 citations

Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major.

Renzo Galanello, Antonio Piga, Gian Luca Forni et al. · PubMed · 2006 · 139 citations

High Incidence and Allelic Homogeneity of Wilson Disease in 2 Isolated Populations: A Prerequisite for Efficient Disease Prevention Programs

Antonietta Zappu, Magli Olympia, Maria Barbara Lepori et al. · Journal of Pediatric Gastroenterology and Nutrition · 2008 · 47 citations

The homozygosity index (HI) approach reveals high allele frequency for Wilson disease in the Sardinian population

Alessandro Gialluisi, Simona Incollu, Tommaso Pippucci et al. · European Journal of Human Genetics · 2013 · 47 citations · Full text

Allelic Variant, Haplotype Determination, Genotype-phenotype Association +13

The canine copper toxicosis gene MURR1 is not implicated in the pathogenesis of Wilson disease

Mario Lovicu, Valeria Dessì, Maria Barbara Lepori et al. · Journal of Gastroenterology · 2006 · 35 citations

Bioactive Metal, Genetics, Pathogenesis +4